A patient discloses several concerns and associated feelings. If the nurse wants to seek clarification, which comment would be appropriate?

Choice A reason: Justice ensures fair treatment across patients. Different interventions (restraint vs. supervision) for self-mutilation, possibly due to serotonin dysregulation, must be equitably applied based on clinical need, not bias. Ensuring consistent, fair application of interventions aligns with justice, addressing ethical concerns about differential treatment in psychiatric care.

Choice B reason: Autonomy involves respecting patient choices, but self-mutilation, driven by impulsivity or emotional dysregulation, requires safety interventions overriding choice. Restraint and supervision prioritize safety over autonomy, making this principle less relevant than justice, which focuses on equitable treatment across patients in this scenario.

Choice C reason: Fidelity emphasizes keeping promises or loyalty to patients, not the fairness of intervention choices. While trust is crucial, the concern here is equitable treatment for self-mutilation, not commitment to promises. Fidelity is secondary to justice in addressing differential interventions, making it incorrect.

Choice D reason: Beneficence focuses on doing good, like preventing harm in self-mutilation. Both restraint and supervision aim to protect, but the ethical concern is fairness, not benefit. Justice addresses equitable application of interventions, making beneficence less directly applicable to the ethical dilemma described.

Choice A reason: Decreasing dopamine is used for disorders like schizophrenia, where excess mesolimbic dopamine causes hallucinations. Memory difficulties, often linked to Alzheimer’s, involve cholinergic deficits, not dopamine excess. Reducing dopamine could worsen cognition by disrupting reward and attention pathways, making this approach scientifically inappropriate for memory issues.

Choice B reason: Inhibiting GABA production is irrelevant for memory. GABA regulates neural inhibition, and its reduction could increase excitability, worsening conditions like seizures. Memory deficits, particularly in dementia, stem from reduced acetylcholine in the hippocampus, not GABA, making this option misaligned with the neurobiology of memory impairment.

Choice C reason: Preventing acetylcholine destruction, via cholinesterase inhibitors, enhances cholinergic activity in the hippocampus and cortex, critical for memory in conditions like Alzheimer’s. Low acetylcholine levels impair neural signaling, causing memory deficits. This approach directly addresses the neurochemical basis of memory difficulties, making it scientifically appropriate for treatment.

Choice D reason: Increasing dopamine sensitivity is relevant for disorders like Parkinson’s, not memory deficits. Dopamine affects motivation and movement, not memory, which relies on acetylcholine in the hippocampus. Enhancing dopamine could disrupt cognitive balance, worsening memory without addressing the cholinergic deficits central to memory impairment.